1. Home
  2. HTH vs FOLD Comparison

HTH vs FOLD Comparison

Compare HTH & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hilltop Holdings Inc.

HTH

Hilltop Holdings Inc.

HOLD

Current Price

$34.70

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.88

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTH
FOLD
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2004
2007

Fundamental Metrics

Financial Performance
Metric
HTH
FOLD
Price
$34.70
$9.88
Analyst Decision
Hold
Buy
Analyst Count
2
7
Target Price
$34.00
$30.29
AVG Volume (30 Days)
365.5K
4.5M
Earning Date
10-23-2025
11-04-2025
Dividend Yield
2.09%
N/A
EPS Growth
53.28
N/A
EPS
2.50
N/A
Revenue
$1,259,399,000.00
$598,704,000.00
Revenue This Year
N/A
$21.12
Revenue Next Year
$1.64
$21.23
P/E Ratio
$13.76
N/A
Revenue Growth
7.66
21.28
52 Week Low
$26.67
$5.51
52 Week High
$36.14
$10.57

Technical Indicators

Market Signals
Indicator
HTH
FOLD
Relative Strength Index (RSI) 57.60 63.10
Support Level $34.32 $9.63
Resistance Level $35.35 $10.05
Average True Range (ATR) 0.75 0.38
MACD 0.07 -0.02
Stochastic Oscillator 79.87 47.31

Price Performance

Historical Comparison
HTH
FOLD

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: